Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER × pycnogenols × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cyclophosphamide 950 Radiotherapy 839 Cisplatin 748 Gemcitabine 655 Carboplatin 600 Docetaxel 597 Paclitaxel 581 Bevacizumab 572 Fluorouracil 500 Oxaliplatin 455 Rituximab 452 Surveys and Questionnaires 443 Capecitabine 439 Dexamethasone 425 Doxorubicin 420 Etoposide 409 Irinotecan 386 Cytarabine 375 Filgrastim 369 pembrolizumab 317 Leucovorin 303 fludarabine phosphate 294 Melphalan 288 Nivolumab 287 Peripheral Blood Stem Cell Transplantation 277 Lenalidomide 276 Blood Specimen Collection 276 Magnetic Resonance Spectroscopy 275 Methotrexate 274 Cetuximab 267

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00214032 2015-10-05

Pycnogenol for the Treatment of Lymphedema

University of Wisconsin, Madison

Phase 2 Completed

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡